Sign In
11 Feb 2019 16:35
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
Ā
11 February 2019
Accrol Group Holdings plc
(AIM: ACRL)Ā
Ā
Director's Dealing
Ā
Accrol Group Holdings plc (the "Company" or "Accrol"), the AIM-listed leading independent tissue converter,Ā announces that, Dan Wright, Executive Chairman of Accrol has today purchased 150,000Ā ordinary shares of Ā£0.001 each ("Ordinary Shares") at a price of 20.5p per Ordinary Share. Following this purchase, he now holds 2,370,308 Ordinary Shares representing 1.21% of the current Issued Share Capital of the Company.
Ā
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Ā
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
Ā
1 | Details of the person discharging managerial responsibilities / person closely associated | ||
a) | Name | Dan Wright Ā | |
2 | Reason for the notification | ||
a) | Position/status | Executive Chairman Ā | |
b) Ā | Initial notification /Amendment | Initial notification | |
3 Ā | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||
a) | Name | Accrol Group Holdings plc | |
b) | LEI | 213800MC56M5G69RJ226 | |
4 Ā | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
a) Ā | Description of the financial instrument, type of instrument Identification code | Ordinary shares of Ā£0.001 Ā ISIN: GB00BZ6VT592 | |
b) | Nature of the transaction | Purchase of Ordinary Shares | |
c) | Price(s) and volume(s) | Price(s) 20.5p Ā | Volume(s) 150,000 Ā |
d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | |
e) | Date of the transaction | 11 February 2018 | |
f) | Place of the transaction | London Stock Exchange, AIM | |
Ā
Ā
Enquiries:
Ā
Ā
For further information, please contact: | Ā | ||
Ā | Ā | ||
Accrol Group Holdings plc | Ā | ||
Dan Wright, Executive Chairman | +44 (0) 1254 278 844 | ||
Gareth Jenkins, Chief Executive Officer | +44 (0) 1254 278 844 | ||
Ā | Ā | ||
Zeus Capital Limited (Nominated Adviser & Broker)Ā | Ā | ||
Dan Bate / Andrew Jones | +44 (0) 161 831 1512 | ||
Dominic King / John Goold | +44 (0) 203 829 5000 | ||
Ā | Ā | ||
Belvedere Communications Limited | Ā | ||
Cat Valentine (cvalentine@belvederepr.com) | +44 (0) 7715 769 078 | ||
| +44 (0) 7967 816 525 | ||
Llew Angus (langus@belvederepr.com) | +44 (0) 7407 023 147 |
Ā
Notes to Editors
Ā
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.Ā
Ā
Accrol operates from three sites:
Ā
Ā· A manufacturing, storage and distribution facility in Blackburn;
Ā· A facial tissue plant, also in Blackburn; and
Ā· A manufacturing, storage and distribution facility in Leyland.
Follow the stocks
